The Journal of Parkinson's Disease, published by IOS PRESS, is a premier open-access journal dedicated to advancing the understanding of Parkinson's Disease and related disorders. Established in 2011, the journal has swiftly gained recognition, achieving impressive rankings within its field: it ranks Q1 in Neurology (clinical) and Q2 in Cellular and Molecular Neuroscience as of 2023. With an impact factor indicative of its rigorous peer-review process and scholarly contribution, the journal stands at the forefront of medical research, particularly positioned within the top 15% of clinical neurology journals worldwide. The journal's open access since 2023 ensures that vital research is readily available to the global scientific community, facilitating knowledge exchange and collaboration. Covering a broad spectrum of topics from basic molecular mechanisms to clinical treatments, the Journal of Parkinson's Disease serves as an essential resource for researchers, clinicians, and students dedicated to tackling one of the most challenging neurodegenerative conditions.

npj Parkinsons Disease is a leading open-access journal dedicated to advancing research in the field of Parkinson's disease and related neurodegenerative disorders. Published by NATURE PORTFOLIO, this journal has been on the forefront of scientific inquiry since its inception in 2015, providing a high-quality platform for the dissemination of groundbreaking research. The journal's reputation is underscored by its impressive Q1 rankings in Cellular and Molecular Neuroscience and Neurology categories, as well as its commendable positions in Scopus rankings, placing it within the top echelons of neuroscience and clinical neurology research. With its focus on innovative methodologies and translational studies, npj Parkinsons Disease aims to foster collaboration among researchers, clinicians, and healthcare professionals, ultimately contributing to the improved understanding and treatment of Parkinson's disease. Researchers, professionals, and students are encouraged to explore its rich repository of knowledge, accessible freely since its launch, to stay abreast of the latest developments in this critical area of neuroscience.

Journal of Neuromuscular Diseases, published by IOS PRESS, is a leading platform dedicated to advancing the field of neurology and neuromuscular research. With a focus on delivering high-quality, peer-reviewed content, this journal aims to foster knowledge sharing and collaboration among researchers, clinicians, and healthcare professionals dealing with neuromuscular disorders. The journal boasts a commendable impact factor within its respective categories, achieving Q2 rankings in both Neurology and Clinical Neurology as of 2023. Spanning from its inception in 2014 to the anticipated convergence in 2024, it is recognized for its contributions to critical discussions in the field, evidenced by its rankings of #145 out of 400 in clinical neurology and #75 out of 192 in neuroscience. As an open access journal, it facilitates wider accessibility of research findings, catering to an audience eager for innovative approaches and developments. Set against the backdrop of the vibrant academic scene in the Netherlands, the Journal of Neuromuscular Diseases serves as an essential resource for driving forward the boundaries of knowledge in neuromuscular-related conditions.

The Journal of Translational Internal Medicine is a renowned platform dedicated to advancing the field of internal medicine through the dissemination of high-quality research and innovative clinical practices. Published by SCIENDO, this journal boasts a respectable Q2 ranking in the Internal Medicine category and is placed in the 69th percentile among its peers, highlighting its significant contribution to the discipline. With its ISSN 2450-131X and E-ISSN 2224-4018, the journal offers an open-access format, promoting accessibility to vital research findings for professionals and scholars around the globe. Located in Poland, the journal has been a valuable resource since its inception in 2018, and it continues to thrive through 2024 and beyond, supporting the objective of translating research into practice, enhancing patient care, and fostering collaboration among researchers and healthcare providers. This makes it an essential read for anyone invested in improving medical outcomes and understanding the evolving challenges faced in internal medicine.

Reumatismo is a distinguished Open Access journal dedicated to the field of rheumatology, published by PAGEPRESS PUBL since 2001. With a rich history dating back to 1952, this journal has been pivotal in disseminating vital research on rheumatic diseases and related disorders. Based in Italy, Reumatismo has earned a reputation for its quality and relevance, achieving a Q3 category ranking in the 2023 Scopus metrics for Rheumatology, reflecting its significant contributions to the field. The journal is committed to providing a platform for the latest scientific developments and clinical innovations, thus aiding researchers, healthcare professionals, and students striving to enhance understanding and treatment of rheumatic conditions. For those seeking to access comprehensive research articles and studies, Reumatismo boasts an open access policy, ensuring that knowledge is freely available to all, fostering collaboration and advancement in rheumatology worldwide.

NEUROSURGERY, published by Lippincott Williams & Wilkins, stands as a foremost journal in the field of clinical neurology and surgery, reflecting a commitment to advancing knowledge and practice through high-quality research and discourse. With an impact factor indicative of its scholarly significance and a remarkable Scopus ranking placing it in the Q1 category for both neurology and surgery, this journal provides a vital platform for clinicians, researchers, and students to explore cutting-edge developments and innovations. NEUROSURGERY publishes peer-reviewed articles that span the spectrum of neurosurgical practice, from basic science discoveries to clinical applications, fostering a collaborative exchange of ideas and methodologies. Since its inception in 1977, the journal has maintained a focus on delivering substantive research that informs practice and enhances patient care, making it an essential resource for professionals dedicated to the fields of neurology and surgery. The journal is based in India, and while it currently does not offer open access options, its rich archive from 1977 to 2024 ensures a comprehensive repository of knowledge for those engaged in this critical area of medicine.

The Journal of Movement Disorders, published by the Korean Movement Disorders Society, is a premier open access journal dedicated to advancing the field of neurology with a specific focus on movement disorders. Established in 2008 and indexed with ISSN 2005-940X and E-ISSN 2093-4939, this journal plays a vital role in disseminating high-quality research and clinical insights to a global audience. With an impressive Q2 ranking in both Neurology and Clinical Neurology categories for 2023, the journal continues to feature innovative research articles that contribute to better understanding and management of various movement disorders. Ranked 104th out of 400 in Clinical Neurology and 54th out of 192 in Neuroscience, the Journal of Movement Disorders offers an essential platform for researchers, healthcare professionals, and students alike, fostering collaboration and knowledge exchange in a rapidly evolving field.

Clinics in Orthopedic Surgery is a premier open-access journal dedicated to advancing the field of orthopedics, published by the Korean Orthopaedic Association. With its ISSN 2005-291X and E-ISSN 2005-4408, this journal provides a dynamic platform for disseminating high-quality research and clinical insights relevant to orthopedic surgery. Since its inception in 2009, it has established a commendable reputation within the academic community, achieving a Q1 ranking in both Orthopedics and Sports Medicine, and Surgery for 2023, as well as notable Scopus rankings. This journal not only facilitates global access to cutting-edge research but also aims to foster collaboration among researchers, professionals, and students alike. Its comprehensive scope and open-access model enhance the visibility and impact of published works, ensuring that critical advancements in orthopedic knowledge reach a wide audience. As it continues to cover diverse topics within the field through 2024 and beyond, Clinics in Orthopedic Surgery remains an essential resource for those invested in orthopedic practice and surgery.

ANNALS OF NONINVASIVE ELECTROCARDIOLOGY is a peer-reviewed journal published by WILEY that has been pivotal in advancing the field of cardiology since its inception in 1996. With an ISSN of 1082-720X and an E-ISSN of 1542-474X, this journal offers open access to its research since 2020, reflecting a commitment to disseminating knowledge widely within the academic community. The journal operates from the United Kingdom, and its current category quartiles—Q3 in Cardiology and Cardiovascular Medicine, Medicine (miscellaneous), and Physiology (medical)—underscore its relevance to these dynamic fields. Although currently ranked in the 53rd percentile for Cardiology and Cardiovascular Medicine and 39th percentile in the Physiology category according to Scopus rankings, the ANNALS OF NONINVASIVE ELECTROCARDIOLOGY aspires to foster impactful research relating to noninvasive electrocardiology techniques, offering insights into cardiovascular health without the need for invasive procedures. This is particularly important as noninvasive methods continue to evolve and influence clinical practices. For researchers, professionals, and students alike, this journal serves as a vital resource for current studies, innovative methodologies, and breakthroughs in the understanding of cardiovascular functions.

PARKINSONISM & RELATED DISORDERS, published by Elsevier Science Ltd, is a prominent peer-reviewed journal dedicated to advancing the understanding of Parkinson's disease and related neurodegenerative disorders. With an impact factor placing it in the Q2 category across multiple fields including Geriatrics and Gerontology and Neurology for 2023, this journal serves as a crucial platform for researchers, healthcare professionals, and students alike. Covering an array of topics from clinical trials to innovative therapeutic strategies, it aims to disseminate valuable insights that can improve patient care and outcomes. While it remains a subscription-based journal, its relevance is underscored by its consistent rankings in Scopus, where it ranks 105th in Clinical Neurology and 35th in Geriatrics and Gerontology. Authored by top scholars in the field, PARKINSONISM & RELATED DISORDERS continues to contribute significantly to the body of knowledge surrounding these debilitating conditions, facilitating the exchange of cutting-edge research and fostering collaboration within the scientific community.